POLIANI, PIETRO LUIGI
 Distribuzione geografica
Continente #
AS - Asia 2.820
NA - Nord America 1.184
EU - Europa 1.026
SA - Sud America 540
AF - Africa 42
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.615
Nazione #
SG - Singapore 1.408
US - Stati Uniti d'America 1.119
CN - Cina 784
BR - Brasile 463
HK - Hong Kong 383
RO - Romania 263
IT - Italia 194
DE - Germania 137
RU - Federazione Russa 115
SE - Svezia 96
VN - Vietnam 94
FI - Finlandia 39
IN - India 34
AR - Argentina 33
PL - Polonia 33
GB - Regno Unito 31
NL - Olanda 30
AT - Austria 26
CA - Canada 26
MX - Messico 25
IQ - Iraq 18
JP - Giappone 17
BD - Bangladesh 15
FR - Francia 15
ZA - Sudafrica 15
EC - Ecuador 12
IE - Irlanda 11
ES - Italia 10
PK - Pakistan 10
CO - Colombia 8
ID - Indonesia 7
PY - Paraguay 7
TR - Turchia 7
KE - Kenya 6
KR - Corea 6
LT - Lituania 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
UA - Ucraina 5
EG - Egitto 4
IL - Israele 4
MA - Marocco 4
NI - Nicaragua 4
TN - Tunisia 4
ET - Etiopia 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
GA - Gabon 2
JO - Giordania 2
KG - Kirghizistan 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
MY - Malesia 1
NA - Namibia 1
NR - Nauru 1
PE - Perù 1
PH - Filippine 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.615
Città #
Singapore 751
Hong Kong 383
Dallas 294
Shanghai 218
Hefei 168
Beijing 161
Ashburn 144
Milan 55
New York 53
Los Angeles 52
São Paulo 49
Munich 47
Nuremberg 39
Ho Chi Minh City 34
Lawrence 34
Princeton 34
Warsaw 31
Moscow 29
Boardman 28
Helsinki 19
Rio de Janeiro 18
Amsterdam 17
Rome 17
Santa Clara 17
Brooklyn 15
Montreal 15
Tokyo 15
Assago 14
Chennai 12
Hanoi 12
Lappeenranta 12
Orem 12
Stockholm 12
Denver 11
Dublin 11
Mexico City 11
Atlanta 10
Belo Horizonte 10
Chicago 10
Da Nang 10
Houston 10
Vienna 10
Campinas 9
Falkenstein 9
Mumbai 8
Seattle 8
Baghdad 7
Guangzhou 7
Johannesburg 7
Phoenix 7
The Dalles 7
Boston 6
Brasília 6
Manchester 6
Nairobi 6
Poplar 6
Romagnano Sesia 6
Toronto 6
Turku 6
Caxias do Sul 5
Curitiba 5
Dhaka 5
Guayaquil 5
London 5
Montevideo 5
Santiago 5
Tianjin 5
Turin 5
Wolfhagen 5
Biên Hòa 4
Cesano Boscone 4
Charlotte 4
Council Bluffs 4
Goiânia 4
Ipatinga 4
Juiz de Fora 4
Kassel 4
Managua 4
Natal 4
Paris 4
Piracicaba 4
Porto Alegre 4
Querétaro 4
Quito 4
Ribeirão Preto 4
Salvador 4
Sapucaia do Sul 4
Shenzhen 4
Thái Bình 4
Addis Ababa 3
Almenara 3
Alvorada 3
Ankara 3
Bogotá 3
Cape Town 3
Cleveland 3
Columbus 3
Contagem 3
Dalian 3
Erbil 3
Totale 3.184
Nome #
Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma 359
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID 77
A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome 77
A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines 76
Absence of Rac1 and Rac3 GTPases in the nervous system hinders thymic, splenic and immune-competence development 75
FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration 70
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients 69
18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis 61
The influence of cystathionine on neurochemical quantification in brain tumor in vivo MR spectroscopy 61
Thymic Epithelial Cell Alterations and Defective Thymopoiesis Lead to Central and Peripheral Tolerance Perturbation in MHCII Deficiency 61
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease 60
Altered function of the glutamate–aspartate transporter GLAST, a potential therapeutic target in glioblastoma 58
Teaching NeuroImage: Spontaneously Resolving Ring-Enhancing Lesions Due to Immunodeficiency-Associated CNS Lymphoma: A Case of "Vanishing Lymphoma" 56
Adult type diffuse gliomas in the new 2021 WHO Classification 56
Increased preoperative levels of circulating erythrocytic hemoglobin are independent predictors for high-grade histology in falcine and parasagittal meningiomas 53
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 53
Central nervous system marginal zone B-cell lymphoma associated with chlamydophila psittaci infection 53
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 53
Anti-CD3{epsilon} mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications 51
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal 51
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation 51
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 51
Gene signatures associated with mouse postnatal hindbrain neural stem cells and medulloblastoma cancer stem cells identify novel molecular mediators and predict human medulloblastoma molecular classification 51
Critical role for prokineticin 2 in CNS autoimmunity 51
Arrangement of live human cells through acoustic waves generated by piezoelectric actuators for tissue engineering applications 50
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth 50
A multimodal staged approach for the resection of a Sylvian aqueduct rosette-forming glioneuronal tumor: A case report and literature review 49
Abnormalities of thymic stroma may contribute to immune dysregulation in murine models of leaky severe combined immunodeficiency 49
TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways 48
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 48
Brain lipid composition in grey-lethal mutant mouse characterized by severe malignant osteopetrosis 47
The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1 46
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 45
A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice 43
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 43
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 43
mTORC1 promotes malignant large cell/ anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma 42
In vivo chronic stimulation unveils autoreactive potential of Wiskott-Aldrich syndrome protein-deficient b cells 42
Corticotroph aggressive pituitary tumours and carcinomas frequently harbour ATRX mutations 41
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience 41
EBF1 is expressed in pericytes and contributes to pericyte cell commitment 41
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 41
EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay 40
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 39
Expression of tert Prevents ALT in Zebrafish Brain Tumors 39
Author Correction: Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (Nature Medicine, (2020), 26, 1, (131-142), 10.1038/s41591-019-0695-9) 39
Immunophenotypic and genotypic analysis of a case of primary peripheral primitive neuroectodermal tumour (pPNET) of the urinary bladder 39
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis 38
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas 37
PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases 37
Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study 37
H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology 36
Lentiviral-mediated gene therapy leads to improvement of B-cell functionality in a murine model of Wiskott-Aldrich syndrome 36
Sellar metastasis from clear cell sarcoma: Description of the first case 36
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 35
Cytokines and immunity in multiple sclerosis: the dual signal hypothesis 35
Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System 35
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas 34
Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review 34
Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma 34
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice 34
Central Nervous system delivery of Interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination 34
Cytokines and immunity in multiple sclerosis: the dual signal hypothesis 34
Human Peripheral Lymphoid Tissues Contain Autoimmune Regulator-Expressing Dendritic Cells 34
High-Definition 3-Dimensional Exoscope for 5-ALA Glioma Surgery: 3-Dimensional Operative Video 33
The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation 33
Caveolin-1, Caveolin-2 and Cavin-1 are strong predictors of adipogenic differentiation in human tumors and cell lines of liposarcoma 33
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 33
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 33
Homozygous DNA ligase IV R278H mutation in mice leads to leaky SCID and represents a model for human LIG4 syndrome 32
β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice 32
Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D-3 31
Central nervous system delivery of therapeutic genes using viral vectors as an alternative strategy in autoimmune demyelinating diseases 31
Gene Therapy: a Possible Future Option for MS 31
Glioblastoma models driven by different mutations converge to the proneural subtype 30
Lactotroph PitNET/adenoma associated to granulomatous hypophysitis in a patient with Crohn's disease: A case report 30
Diagnosis and Treatment of Pineal Region Tumors in Adults: A EURACAN Overview 30
Immunogene therapy for autoimmune demyelination 30
The role of proinflammatory cytokiens in multiple slcerosis 30
Primary primitive peripheral neuroectodermal tumor of the prostate. Immunophenotypic and molecular study of a case 30
Thymic epithelium abnormalities in DiGeorge and Down syndrome patients contribute to dysregulation in T cell development 30
Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency 29
Correction of Murine Rag2 Severe Combined Immunodeficiency by Lentiviral Gene Therapy Using a Codon-optimized RAG2 Therapeutic Transgene 29
The pathogenic role of inflammation in multiple sclerosis 29
Plurihormonal, functioning ACTH-GH pituitary adenoma: case report and systematic literature review 29
Dexamethasone inhibits the anti-tumor effect of interleukin-4 on rat experimental gliomas 29
Hypomorphic mutation in the RAG2 gene affects dendritic cell distribution and migration 29
Constitutional de novo deletion of the FBXW7 gene in a patient with focal segmental glomerulosclerosis and multiple primitive tumors 29
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 29
DNA threads released by activated CD4+ T lymphocytes provide autocrine costimulation 28
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas 28
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 28
Exacerbation of experimental autoimmune encephalomyelitis by passive transfer of IgG antibodies from a multiple sclerosis patient responsive to immunoadsorption 28
Rag defects and thymic stroma: lessons from animal models 28
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 28
Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit(W-sh/W-sh) mice 28
Caspase-1 regulates the inflammatory process leading to autoimmune demyelination 28
Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. 28
Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes 28
Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models 28
Totale 4.411
Categoria #
all - tutte 39.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 2 0 2 0 0 0
2021/202216 0 0 0 8 1 0 0 0 1 5 0 1
2022/2023191 79 33 11 2 3 23 9 10 5 0 3 13
2023/2024370 20 6 13 21 22 28 8 25 1 5 118 103
2024/20252.344 330 31 15 53 55 166 618 180 345 200 143 208
2025/20262.935 549 522 360 886 493 125 0 0 0 0 0 0
Totale 5.872